Get access to all our reports for $50/mo
Read about the latest in the private markets and join a growing community.
- Valuation Model
- Expert Interviews
- Founders, funding
What is driving higher adoption of stem cell preservation in China and Singapore, and what factors could drive adoption in the U.S.?
Kathryn Cross
Co-founder & CEO at Anja Health
The US definitely could hit those numbers. There are parents I speak with all the time who say that they wish they’d known about it sooner. More often than not, though, I’m meeting parents who never heard about this before—that just goes to show there's a lot of room for parents to be educated and potentially reach similar levels to other countries.
Find this answer in
Kathryn Cross, CEO of Anja Health, on the future of stem cell therapy
Unlocked Report